You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company is conducting a directed new issue of shares, which is expected to add close to SEK 5.3 million to NeuroVive. Proceeds from the new share issue will be used primarily for continued clinical development of KL1333 and NeuroSTAT. NeuroVive's Board of Directors has decided to conductAlready a subscriber Login You…
Vakona has been given a capital injection from five investors to help it develop a new drug to treat acne. “This is a significant investment for us, as now we can continue with our product development," says Gabriella Persson, CEO of Vakona. Three of the investors, Stoaf III SciTech, PartnerAlready…
With this new issue of shares OssDsign adds about 151.3 million SEK and around 2000 new owners. "It is of course very gratifying to see a great interest in OssDsign and that we have been able to both attract well renowned institutional owners and achieve a broad dispersion in our…
The double-digit million DKK investment is to set up a new storage and CTS production facility for the pharmaceutical and biotech industries. The expansion site is situated in the Greater Copenhagen area in Medicon Valley. “Through this strategic investment, we are fortifying KLIFO’s foothAlready a subscriber Login You have read…
